Question Everything. See who's reporting it.

India approves first dengue vaccine Qdenga for 4-60 age group

Source: Indian Express

The story in brief

India’s first dengue vaccine, Qdenga, has been approved by the DCGI for use in people aged 4 to 60. Developed by Takeda, it marks a key milestone in combating dengue, a major public health issue. The approval expands access to preventive measures for children and adults. The DCGI, India’s drug regulator, gave the green light after thorough review. This development is expected to boost dengue prevention efforts nationwide.

NEWXFree on Android and iPhone. Open in NEWX